Leading a compassionate new era in medicine.
Comera is built on the belief that true medical advances are inspired by compassion. By scientific innovators seeing themselves in patients and their families. Feeling their burden. And being moved to do something about it.
Our mission is to help patients live their best life possible.
Millions of patients with serious or chronic conditions rely on biologic medicines that are primarily administered intravenously.
The power of science to free patients.
Our focus is on patients who depend on intravenous (“IV”) biologics for treating significant disease – with few or no other options. These patients are forced to spend hours at infusion centers on a regular basis. We seek to transform their biologic therapies into gentler subcutaneous (“SQ”) forms they can administer themselves.
Through the freedom of self-injectable care, we hope to relieve patients from the logistical burden of receiving their therapy and make patients’ lives more livable.
Who We Are
A life sciences company…
Comera is dedicated to realizing the full potential of life-changing biologic therapeutics through our innovative SQore™ platform. SQore is our foundation for developing a pipeline of single-dose, self-injectable SQ biologics and collaborating with biopharmaceutical companies to enhance the delivery and characteristics of their own biologic formulations.
…turning IV to SQ.
We address the formulation challenges of SQ biologics by engineering the innovative use of proprietary excipients. Our excipients have the potential to improve the delivery of highly viscous biologics without compromising the tolerability and efficacy of the active drug.
Expanding our impact.
Our dedication to improving lives extends beyond patients to the people we work with, for, and among.
The people behind new possibilities.
Our company is led by people with deep expertise in product development, polymer engineering, interfacial dynamics and traditional protein chemistry. People who use that knowledge to change what’s possible.